Influvac News
Most Popular Influvac Story
Report: Abbott looking to sell Solvay's flu vax unit
Illinois drugmaker Abbott Laboratories is reportedly looking to sell the flu vaccine business it picked up in its recent purchase of Solvay pharmaceutical unit, in a deal potentially worth €500 Read more...
Latest Headlines
- June 30, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
